References
- Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 1984; 6: 128–133
- Benson M D. Familial amyloidotic polyneuropathy. Trends Neurosci 1989; 12: 88–92
- Benson M D. Amyloidosis. Metabolic and Molecular Bases of Inherited Disease, Seventh Edition, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. McGraw Hill Book Co., New York, NY 1995; 4159–4191
- Saraiva M JM. Transthyretin mutations in health and disease. Hum Mutat 1996; 5: 191–196
- Benson M D, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996; 3: 44–56
- Dwulet F E, Benson M D. Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun 1983; 114: 657–662
- Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880–888
- Madisen L, Hoar D I, Holroyd C D, Crisp M, Hodes M E. DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet 1987; 27: 379–390
- Nichols W C, Benson M D. Hereditary amyloidosis: detection of variant prealubumin genes by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1990; 37: 44–53
- Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K. Structure of human prealbumin gene. J Biol Chem 1985; 260: 12224–12227
- Stevens J C. AAEE Minimonograph #26: The electrodiagnosis of carpal tunnel syndrome. Muscle Nerve 1987; 10: 99–113
- Reilly M M, Adams D, Booth D R, Davis M B, Said G, Laubriat-Bianchin M, Pepys M B, Thomas P K, Harding A E. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995; 118: 849–856
- Uemichi T, Ueno S, Fujimura H, Umekage T, Yorifuji S, Matsuzawa Y, Tarui S. Familial amyloid polyneuropathy related to transthyretin Gly42 in a Japanese family. Muscle Nerve 1992; 15: 904–911
- Booth D R, Soutar A K, Hawkins P N, Reilly M, Harding A, Pepys M B. Three new amyloidogenic transthyretin gene mutations: Advantages of direct sequencing. Amyloid and Amyloidosis, R Kisilevsky. The Parthenon Pub. Group, Inc., London and New York, NY 1993; 456–458
- Saeki Y, Ueno S, Takahashi N, Soga F, Yanagihara T. A novel mutant (transthyretin Ile-50) related to amyloid polyneuropathy. FEBS Lett 1992; 308: 35–37
- Booth D R, Tan S Y, Hawkins P N, Pepys M B, Frustaci A. A novel variant of transthyretin, 59th-lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995; 91: 962–967
- Sousa A, Coelho T, Lobato L. Parental transmission and anticipation of age of onset in FAP-I. Am J Hum Genet Suppl 1991; 49: A2757
- Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: A pedigree analysis. J Med Genet 1993; 30: 388–392
- Tashima K, Ando Y, Tanaka Y, Uchino M, Ando M. Change in the age of onset in patients with familial amyloidotic polyneuropathy type I. Intern Med 1995; 34: 748–750
- Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998; 35: 23–30
- Hayashi K. PCR-SSCP: a method for detection of mutations. GATA 1992; 9: 73–79
- Hayashi K, Yandell D W. How sensitive is PCR-SSCP?. Hum Mutat 1993; 2: 338–346
- Goldrick M M, Kimball G R, Liu Q, Martin L A, Sommer S S, Tseng P Y. NIRCA: a rapid robust method for screening for unknown point mutations. BioTechniques 1996; 21: 106–112